GGrantIndex
← Search

DEVELOPMENT OF A GUT MICROBIOME-BASED PROGNOSTIC SIGNATURE PREDICTING RISK OF HEPATOCELLULAR CANCER RECURRENCE AFTER ABLATIVE THERAPIES

$295,327FY2021Defense Health AgencyDOD

The University Of Texas Southwestern Medical Center

Investigators

View source on USAspending →
DEVELOPMENT OF A GUT MICROBIOME-BASED PROGNOSTIC SIGNATURE PREDICTING RISK OF HEPATOCELLULAR CANCER RECURRENCE AFTER ABLATIVE THERAPIES · GrantIndex